eGenesis is a biotechnology company using multiplex gene editing and genome engineering to develop genetically engineered porcine organs for human transplantation and address donor-organ shortages.
Products & media
Investigational gene-edited porcine kidney for transplantation in people with kidney failure, evaluated through expanded access and an FDA-cleared clinical development program.
Investigational gene-edited porcine liver used with OrganOx's extracorporeal system to support patients with acute-on-chronic liver failure.
Investigational gene-edited porcine heart program developing organs for transplantation to address the shortage of donor hearts for people with heart failure.
Jobs
See all jobs for eGenesis here.
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Leads
Participating Firms
Angels